The previous concept defines the role of CD4+ T cells in anti-tumour immunity as indirect, mainly through Th cells to support CD8+ T cell-mediated tumour killing or Tregs to limit this class response (76, 77). The gene discussed is CD8A; the disease is neoplasm.